title: The effect of antibacterial monomer MDPB on the growth of organisms associated with root caries.
abstract: MDPB, 12-methacryloyloxydodecylpyridinium bromide, was tested for its ability to inhibit the growth of organisms associated with active root caries lesions and to modify the growth characteristics of these organisms at sub-MICs. MICs and MBCs of MDPB for independent isolates (n=5) of the following taxa: Streptococcus mutans, Streptococcus oralis, Streptococcus salivarius, Actinomyces naeslundii, Actinomyces israelii, Actinomyces gerensceriae, Actinomyces odontolyticus, Lactobacillus spp., and Candida albicans were determined, and the effects at sub-MIC on microbial growth kinetics were assessed. All isolates were sensitive to inhibition by MDPB. The median MICs and MBCs of MDPB for these organisms were in the range of 3.13 to 25.0 microg/ml and 6.25 to 50.0 microg/ml, respectively. As for the influence of pH, inhibition was sensitive to acidic pH. Even at sub-MICs, the growth of all strains, measured as cell yield and doubling time, was significantly reduced. Based on the results of this study, MDPB exhibited the potential to inhibit the growth of microbiota associated with active root caries lesions.
authors: Department of Operative Dentistry, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi, Osaka 573-1121, Japan.
authors: Kazushi
authors: K
authors: Yoshikawa
authors: Douglas T
authors: DT
authors: Clark
authors: Susan R
authors: SR
authors: Brailsford
authors: David
authors: D
authors: Beighton
authors: Timothy F
authors: TF
authors: Watson
authors: Satoshi
authors: S
authors: Imazato
authors: Yasuko
authors: Y
authors: Momoi
mesh_terms: D000190:Actinomyces / Q000187:drug effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects; D006736:Horses; D007778:Lactobacillus / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011726:Pyridinium Compounds / Q000494:pharmacology*; D017213:Root Caries / Q000188:drug therapy / Q000382:microbiology*; D013291:Streptococcus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D011726:Pyridinium Compounds; C089392:methacryloyloxydodecylpyridinium bromide